Latest Headlines

  1. Emerson Streamlines Life Sciences Recipe Creation For Faster Time To Market 3/9/2026
  2. Forma Life Sciences Launches U.S. Based Contract Development And Manufacturing Organization (CDMO) For Oral Solid Dosage Development And Commercial Manufacturing In Irvine, California 3/6/2026

    Forma Life Sciences, Inc. today announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product manufacturing in the United States.

  3. Join Esco At INTERPHEX 2026 3/3/2026
  4. Ensorcell Appoints Biopharma Industry Veterans Geoff Hodge And Amy Teachout To Senior Leadership Team 3/3/2026

    Ensorcell, a company focused on reimaging life science tools and solutions for the biopharmaceutical industry, today announced the appointment of Geoff Hodge and Amy Teachout to its senior leadership team. These appointments reinforce Ensorcell’s commitment to innovation, superb value, and exceptional customer experience as the company continues to expand its capabilities and partnerships across the biopharma ecosystem.

  5. Strategic Oral Solid Dose Facility Investment In Ireland Expands Novo Nordisk's Global Manufacturing Footprint 3/2/2026
  6. Novartis Announces New Radioligand Therapy Manufacturing Facility In Denton, Texas 2/26/2026

    Novartis, a leading global innovative medicines company, today announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas. 

  7. Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment 2/26/2026

    Quotient Sciences, a leading integrated CRDMO, announced an extended commercial supply partnership with Ipsen, a global biopharmaceutical company, to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 people worldwide.

  8. Bora Pharmaceuticals And GSK Sign $250M Five Year Global Manufacturing Contract 2/24/2026

    This renewed collaboration reinforces the long-standing relationship between the two companies and expands the partnership, allowing GSK access to multiple sites within the Bora network, including its newest OSD site in Maple Grove, Minnesota.

  9. AbbVie Announces $380 Million Investment With Two New Active Pharmaceutical Ingredient Manufacturing Facilities In Illinois 2/24/2026

    AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These new state-of-the-art facilities will integrate advanced manufacturing technologies with artificial intelligence (AI) to support the production of AbbVie's next-generation neuroscience and obesity medications.

  10. Johnson & Johnson Announces $1 Billion Investment With New Cell Therapy Manufacturing Facility In Pennsylvania 2/22/2026

    ohnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a more than $1 billion investment in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania. This new facility will further expand the Company’s U.S. manufacturing capacity as it advances its industry leading portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases.